(trans,trans)-4-((E)-Prop-1-en-1-yl)-4'-propyl-1,1'-bi(cyclohexane), 95.0%, 100g

4-Chloro-2-methylbenzyl alcohol, 96.0%, 5g

DL tartaric acid, min. 99.5%, anhydrous, 25 g, plastic packaging.

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)acetamide, 95.0%, 1g

2-Chloro-5-methylpyridine-4-boronic acid, 97%, 10g

m-Anisidine>98.0%(GC)(T)500g

METHYL 3-IODO-1H-INDAZOLE-5-CARBOXYLATE, 97%, 10g

1,1,3,3, Tetraphenyl dimethoxy disiloxane, >90.0%(GC), 5g

Ethyl 2-bromo-5-fluorobenzoate, 95.0%, 25g

5-Methoxy-2-(piperidin-4-yl)-2,3-dihydro-1H-isoindol-1-one hydrochloride, 1g

2,4-Dichloro-5-formylthiazole, 97.0%, 2.5g

2-Amino-6-chloropurine, 97.0%, 10g

1-Benzyl D-Glutamate>98.0%(HPLC)(T)5g